特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
408547

CRISPRの世界市場の将来予測

Global Crispr Market Forecast 2019-2027

出版日: | 発行: Inkwood Research | ページ情報: 英文 158 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
CRISPRの世界市場の将来予測
出版日: 2018年12月10日
発行: Inkwood Research
ページ情報: 英文 158 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のCRISPR市場の将来展望について分析し、技術・関連製品の特性や市場の基本構造、主な促進・抑制要因、市場全体および製品別・エンドユーザー別・用途別・地域別の市場動向見通し (今後9年間分)、主要企業のプロファイルなどを調査しております。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第5章 市場区分

  • 製品別の市場 (今後9年間分)
    • デザインツール
    • プラスミドおよびベクター
    • Cas9ヌクレアーゼおよびgRNA
    • 送達システム
  • エンドユーザー別の市場 (今後9年間分)
    • バイオテクノロジー企業
    • 製薬企業
    • 教育機関
    • 研究機関
  • 用途別の市場 (今後9年間分)
    • ゲノム編集/遺伝子工学
    • gRNAデータベース/遺伝子ライブラリー
    • CRISPRプラスミド
    • ヒト幹細胞
    • 細胞株エンジニアリング

第6章 主要指標

  • ポーターのファイブフォース分析
  • 市場の変遷
  • サプライチェーン分析
  • 規制枠組み
  • バリューチェーン分析
  • 主な購入基準
  • 特許分析
  • 全方位的分析
  • 戦略提言と結論

第8章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、フランス、ドイツ、スペイン、イタリアなど)
  • アジア太平洋地域 (インド、中国、日本、韓国など)
  • 他の国々 (RoW)

第8章 企業プロファイル

  • 企業分析
    • 最大手企業
    • 企業合併・買収 (M&A)
    • 事業提携・提携
    • イノベーション
    • ベンチャーキャピタル融資
  • EDITAS MEDICINE
  • ADDGENE
  • CRISPR THERAPEUTICS AG
  • HORIZON DISCOVERY PLC.
  • SIGMA-ALDRICH (MERCK)
  • GENSCRIPT
  • SANGAMO THERAPEUTICS
  • LONZA GROUP AG
  • INTEGRATED DNA TECHNOLOGIES
  • NEW ENGLAND BIOLABS INC
  • ORIGENE TECHNOLOGIES INC
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • THERMO FISHER SCIENTIFIC
  • CARIBOU BIOSCIENCES INC.
  • PRECISION BIOSCIENCES
  • CELLECTIS BIORESEARCH SAS
  • INTELLIA THERAPEUTICS INC
  • NOVARTIS INTERNATIONAL AG
図表

LIST OF TABLES

  • TABLE 1 GLOBAL CRISPR MARKET BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 2 VARIOUS INITIATIVES AND POLICIES UNDERTAKEN BY THE GOVERNMENT IN HEALTHCARE SECTOR
  • TABLE 3 RISING PUBLIC HEALTH AND LONG-TERM CARE EXPENDITURE OVER THE NEXT DECADES (%)
  • TABLE 4 MAJOR CONCERNS RELATED WITH GENETIC ENGINEERING
  • TABLE 5 GLOBAL CRISPR MARKET BY PRODUCT MARKET 2019-2027 ($ MILLIONS)
  • TABLE 6 TOOLS NAME AND THEIR PROVIDERS
  • TABLE 7 GLOBAL CRISPR MARKET IN DESIGN TOOLS BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 8 GLOBAL CRISPR MARKET IN PLASMIDS AND VECTORS BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 9 GLOBAL CRISPR MARKET IN CAS9 NUCLEASE AND GRNA BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 10 GLOBAL CRISPR MARKET IN DELIVERY SYSTEM BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 11 GLOBAL CRISPR MARKET BY END USER 2019-2027 ($ MILLIONS)
  • TABLE 12 GLOBAL CRISPR MARKET IN BIOTECH FIRMS BY GEOGRAPHY 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL CRISPR MARKET IN PHARMA COMPANIES BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 14 LIST OF TOP UNIVERSITIES AROUND THE WORLD FOR GENETIC ENGINEERING, 2015
  • TABLE 15 GLOBAL CRISPR MARKET IN ACADEMIC INSTITUTIONS BY GEOGRAPHY 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL CRISPR MARKET IN RESEARCH FOUNDATION BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 17 GLOBAL CRISPR MARKET, BY APPLICATION 2019-2027 ($ MILLIONS)
  • TABLE 18 GLOBAL CRISPR MARKET IN GENOME EDITING/ GENETIC ENGINEERING BY TYPES 2019-2027 ($ MILLIONS)
  • TABLE 19 GLOBAL CRISPR MARKET IN GENOME EDITING/ GENETIC ENGINEERING BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 20 BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET
  • TABLE 21 TRAITS AND TECHNOLOGY HISTORY OF PLANT BIOTECH
  • TABLE 22 AGRICULTURE BIOTECH TRAITS INDUSTRY
  • TABLE 23 COMPANY RELATED TO AGRICULTURE BIOTECHNOLOGY INVOLVED IN GENOME EDITING TOOL CRISPR
  • TABLE 24 AGRICULTURAL BIOTECHNOLOGY COMPANY LICENSING CRISPR PRODUCTS
  • TABLE 25 KEY COMPETITORS IN THE AGRICULTURAL BIOLOGICALS INDUSTRY
  • TABLE 26 GLOBAL CRISPR MARKET IN GRNA DATABASE/GENE LIBRARY BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 27 GLOBAL CRISPR MARKET IN CRISPR PLASMID BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 28 GLOBAL CRISPR MARKET IN HUMAN STEM CELLS BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 29 GLOBAL CRISPR MARKET IN CELL LINE ENGINEERING BY GEOGRAPHY 2019-2027 ($ MILLIONS)
  • TABLE 30 GLOBAL CRISPER MARKET, BY GEOGRAPHY 2019-2027 ($ MILLION)
  • TABLE 31 NORTH AMERICA CRISPER MARKET 2019-2027 ($ MILLION)
  • TABLE 32 FUNDS ALLOCATED FOR RESEARCH ACTIVITIES IN BUDGET 2016
  • TABLE 33 GM CROPS GROWN IN CANADA
  • TABLE 34 EUROPE CRISPR MARKET 2019-2027 ($ MILLION)
  • TABLE 35 APAC CRISPR MARKET 2019-2027 ($ MILLIONS)

LIST OF FIGURES

  • FIGURE 1 CAUSES OF DEATHS DURING 2016, WORLDWIDE
  • FIGURE 2 FATALITIES INCREASING DUE TO LIFESTYLE ORIENTED DISEASES (IN THOUSAND)
  • FIGURE 3 REASON FOR OUTSOURCING DRUG DISCOVERY PROJECTS
  • FIGURE 4 GLOBAL CRISPR MARKET IN DESIGN TOOLS 2019-2027 ($ MILLIONS)
  • FIGURE 5 GLOBAL CRISPR MARKET IN PLASMIDS AND VECTORS 2019-2027 ($ MILLIONS)
  • FIGURE 6 GLOBAL CRISPR MARKET IN CAS9 NUCLEASE AND GRNA 2019-2027 ($ MILLIONS)
  • FIGURE 7 GLOBAL CRISPR MARKET IN DELIVERY SYSTEM 2019-2027 ($ MILLIONS)
  • FIGURE 8 GLOBAL CRISPR MARKET IN BIOTECH FIRMS 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL CRISPR MARKET IN PHARMA COMPANIES 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL CRISPR MARKET IN ACADEMIC INSTITUTIONS 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL CRISPR MARKET IN RESEARCH FOUNDATION 2019-2027 ($ MILLIONS)
  • FIGURE 12 GLOBAL CRISPR MARKET IN GENOME EDITING/ GENETIC ENGINEERING 2019-2027 ($ MILLIONS)
  • FIGURE 13 GLOBAL GENOME EDITING/ GENETIC ENGINEERING MARKET IN GENETICALLY MODIFIED ORGANISMS/CROPS 2019-2027 ($ MILLIONS)
  • FIGURE 14 GLOBAL GENOME EDITING/ GENETIC ENGINEERING MARKET IN AGRICULTURAL BIOTECHNOLOGY 2019-2027 ($ MILLIONS)
  • FIGURE 15 GLOBAL GENOME EDITING/ GENETIC ENGINEERING MARKET IN OTHERS 2019-2027 ($ MILLIONS)
  • FIGURE 16 GLOBAL CRISPR MARKET IN GRNA DATABASE/GENE LIBRARY 2019-2027 ($ MILLIONS)
  • FIGURE 17 GLOBAL CRISPR MARKET IN CRISPR PLASMID 2019-2027 ($ MILLIONS)
  • FIGURE 18 GLOBAL CRISPR MARKET IN HUMAN STEM CELLS 2019-2027 ($ MILLIONS)
  • FIGURE 19 GLOBAL CRISPR MARKET IN CELL LINE ENGINEERING 2019-2027 ($ MILLIONS)
  • FIGURE 20 TIMELINE OF GLOBAL CRISPR MARKET
  • FIGURE 21 VALUE CHAIN ANALYSIS
  • FIGURE 22 GLOBAL CRISPR MARKET SHARE BY REGION, 2018 (%)
  • FIGURE 23 NORTH AMERICA CRISPER MARKET 2019-2027 ($ MILLION)
  • FIGURE 24 ADOPTION OF GMO CROPS IN THE U.S. IN 2016 (%)
  • FIGURE 25 THE U.S. CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 26 REASONS FOR ADOPTING GENETICALLY ENGINEERED CROP (BT COTTON)
  • FIGURE 27 GM CROPS GROWN IN CANADA
  • FIGURE 28 CANADA CRISPER MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 EUROPE CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 THE UNITED KINGDOM CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 FRANCE CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 GERMANY CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 SPAIN CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 ITALY CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 REST OF EUROPE CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 INDIA CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 37 CHINA CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 JAPAN CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 SOUTH KOREA CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 REST OF APAC CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 41 REST OF WORLD CRISPR MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 GLOBAL CRISPR MARKET COMPANIES SHARE 2018 (%)
目次
Product Code: 2281

KEY FINDINGS

The Global CRISPR market is expected to witness a boost of 32.04% CAGR over the forecast period of 2019-2027. Factors like increasing demand of the technology for drug discovery, late pregnancies leading to birth disorders and growing investments for path-breaking research technology are fueling the market growth.

MARKET INSIGHTS

The global CRISPR market is segmented on the basis of products, applications, end-users. The product segment includes plasmids and vectors, design tools, Cas9 nuclease and gRNA, and delivery systems. The application segment includes genetic engineering, genome editing, gRNA database/gene library, human stem cells, CRISPR plasmid, genetically modified organisms/crops and cell line engineering. The end-users for the CRISPR market include research foundation, academic institutes, pharma companies and biotech firms.

REGIONAL INSIGHTS

Regional segmentation of the market is done into Europe, Asia-Pacific, North America and rest of the world CRISPR markets. The Asia-Pacific market is expected to register the fastest growth over the forecast period. The region is driven by high population growth in emerging nations of India and China and a growing prevalence of genetic diseases there. The North American market, on the other hand, is predicted to account for the highest revenue share by the end of the forecast period, with the U.S being its major contributor. The presence of leading market companies and growing consumer awareness related to this technology is responsible for propelling this region ahead.

COMPETITIVE INSIGHTS

Thermo Fisher Scientific, Editas Medicine, Crispr Therapeutics Ag, Sigma-Aldrich (Merck), Horizon Discovery Plc, Genscript, Lonza Group Ag, Sangamo Biosciences Inc,Integrated DNA Technologies (IDT), Origene Technologies Inc, New England Biolabs Inc, Transposagen Biopharmaceuticals Inc, Caribou Biosciences Inc, Precision Biosciences, Intellia Therapeutics Inc, Cellectis Bioresearch SAS and Novartis International Ag are few of the companies engaged in the global CRISPR market

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NORTH AMERICA HOLDS THE LARGEST MARKET SHARE
    • 3.2.2. DESIGN TOOLS ARE GROWING AT A FASTER RATE IN TERMS OF PRODUCT
    • 3.2.3. GENOME EDITING/ GENETIC ENGINEERING TO HOLD THE LARGEST SHARE

4. MARKET DETERMINANTS

  • 4.1. DRIVERS
    • 4.1.1. INCREASING DEMAND FOR DRUG DISCOVERY
    • 4.1.2. LATE PREGNANCIES LEADING TO BIRTH DISORDERS
    • 4.1.3. RISK OF CONGENITAL ANAMOLITIES
    • 4.1.4. AGING GENETIC DISORDERS
    • 4.1.5. INVESTMENT IN PATH BREAKING RESEARCH TECHNOLOGY
    • 4.1.6. CHANGING LIFESTYLES
  • 4.2. RESTRAINTS
    • 4.2.1. POSSIBLE MISUSE OF CRISPR GENE EDITING TOOL
    • 4.2.2. LACK OF AWARENESS
    • 4.2.3. LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
  • 4.3. OPPORTUNITIES
    • 4.3.1. GENOME SURGERY TO REWRITE THE GENETIC DISORDERS
    • 4.3.2. CLINICAL TRIALS IN ASIA
  • 4.4. CHALLENGES
    • 4.4.1. PROTECTION OF PATENT
    • 4.4.2. ALTERNATE TECHNOLOGIES
    • 4.4.3. LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY PRODUCT 2019-2027
    • 5.1.1. DESIGN TOOLS
    • 5.1.2. PLASMIDS AND VECTORS
    • 5.1.3. CAS9 NUCLEASE AND GRNA
    • 5.1.4. DELIVERY SYSTEM
  • 5.2. MARKET BY END USER 2019-2027
    • 5.2.1. BIOTECHNOLOGY FIRMS
    • 5.2.2. PHARMACEUTICAL COMPANIES
    • 5.2.3. ACADEMIC INSTITUTES
    • 5.2.4. RESEARCH FOUNDATION
  • 5.3. MARKET BY APPLICATION 2019-2027
    • 5.3.1. GENOME EDITING/ GENETIC ENGINEERING
      • 5.3.1.1. GENETICALLY MODIFIED ORGANISMS
      • 5.3.1.2. AGRICULTURAL BIOTECHNOLOGY
      • 5.3.1.3. OTHERS
    • 5.3.2. GRNA DATABASE/GENE LIBRARY
    • 5.3.3. CRISPR PLASMID
    • 5.3.4. HUMAN STEM CELLS
    • 5.3.5. CELL LINE ENGINEERING

6. KEY ANALYTICS

  • 6.1. PORTER'S 5 FORCE MODEL
    • 6.1.1. THREATS OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. BARGAINING POWER OF BUYER
    • 6.1.4. BARGAINING POWER OF SUPPLIER
    • 6.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.2. MARKET ETYMOLOGY
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. REGULATORY FRAMEWORK
  • 6.5. VALUE CHAIN ANALYSIS
  • 6.6. KEY BUYING CRITERIA
  • 6.7. PATENT ANALYSIS
  • 6.8. 360 DEGREE ANALYSIS
  • 6.9. STRATEGIC RECOMMENDATION AND CONCLUSION

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. ITALY
    • 7.2.6. ROE (REST OF EUROPE)
  • 7.3. ASIA PACIFIC (APAC)
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. SOUTH KOREA
    • 7.3.5. REST OF APAC
  • 7.4. REST OF THE WORLD

8. COMPANY PROFILE

  • 8.1. COMPETITIVE ANALYSIS
    • 8.1.1. TOP COMPANIES
    • 8.1.2. MERGERS AND ACQUISITION
    • 8.1.3. PARTNERSHIPS AND COLLABORATIONS
    • 8.1.4. INNOVATIONS
    • 8.1.5. VENTURE CAPITAL FUNDING
  • 8.2. EDITAS MEDICINE
  • 8.3. ADDGENE
  • 8.4. CRISPR THERAPEUTICS AG
  • 8.5. HORIZON DISCOVERY PLC.
  • 8.6. SIGMA-ALDRICH (MERCK)
  • 8.7. GENSCRIPT
  • 8.8. SANGAMO THERAPEUTICS
  • 8.9. LONZA GROUP AG
  • 8.10. INTEGRATED DNA TECHNOLOGIES
  • 8.11. NEW ENGLAND BIOLABS INC
  • 8.12. ORIGENE TECHNOLOGIES INC
  • 8.13. TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • 8.14. THERMO FISHER SCIENTIFIC
  • 8.15. CARIBOU BIOSCIENCES INC.
  • 8.16. PRECISION BIOSCIENCES
  • 8.17. CELLECTIS BIORESEARCH SAS
  • 8.18. INTELLIA THERAPEUTICS INC
  • 8.19. NOVARTIS INTERNATIONAL AG
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.